Loading...
 
Back to the list
Mediterr J Rheumatol 2016;27(2):36-9
Article Links
Management of gout and hyperuricemia in elderly people
Antonios Schinas1, Maria Chatzipavlou2, Loukia Koutsogeorgopoulou3, Dimitrios Kassimos4
Authors Information

1: Department of Nephrology, 401 General Military Hospital of Athens, Greece

2: Department of Nutrition, 401 General Military Hospital of Athens, Greece

3: Department of Pathophysiology, “Laiko” General Hospital, Athens, Greece

4: Department of Rheumatology, 401 General Military Hospital of Athens, Greece

Keywords: gout, hyperuricemia, elderly, NSAIDs gout, NSAIDs
References
  1. Dieppe P A. Investigation and management of gout in the young and the elderly. Ann Rheum Dis 1991;50:263-6.
  2. Michet C J Jr, Evans J M, Fleming K C. Common rheumatologic diseases in elderly patients. Mayo Clin Proc 1995;1205-14.
  3. Neogi T, Jansen T L, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 Gout Classification Criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Arthritis Rheumatol 2015;67:2557-68.
  4. Stamp L K, Jordan S. The Challenges of Gout Management in the Elderly. Drugs Aging 2011;28:591-603.
  5. Khanna D, Khanna P P, Fitzgerald J D, Singh M K, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 2012;64:1447-61.
  6. Schlesinger N. Anti-interleukin-1 therapy in the management of gout. Curr Rheumatol Rep 2014;16:398.
  7. Schumacher H R, Boice J A, Daikh D I, Mukhopadhyay S, Malmstrom K, et al. Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. BMJ 2002;324:1488-92.
  8. Schumacher H R, Berger M F, Li-Yu J, Perez-Ruiz F, Burgos-Vargas R, Li C. Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial. J Rheumatol 2012;39:1859-66.
  9. Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000;43:103-8.
  10. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2015;63:2227-46.
  11. Daoussis D, Antonopoulos I, Andonopoulos A P. ACTH as a treatment for acute crystal-induced arthritis: update on clinical evidence and mechanisms of action. Semin Arthritis Rheum 2014;43:648-53.
  12. McGonagle D, Tan A L, Shankaranarayana S, Madden J, Emery P, McDermott MF. Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra. Ann Rheum Dis 2007;66:1683-4.
  13. Terkeltaub R. Management of gout and Hyperuricemia. Chapter 189. Hochberg M. Rheumatology. Elsevier, 6th edition 2015. P1575-82.
  14. Rossi-Semerano, Fautrel B, Wendling D, Hachulla E, Galeotti C, Semerano L, et al. Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey. Orphanet J Rare Dis 2015;10:19.
  15. Schlesinger N. Response to application of ice may help differentiate between gouty arthritis and other inflammatory arthritides. J Clin Rheumatol 2006;12:275-6.
  16. Taylor T H, Mecchella J N, Larson R J, Kerin K D, Mackenzie T A. Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized controlled clinical trial. Am J Med 2012;125:1126-34.
  17. Stamp L K, Taylor W J, Jones P B, Dockerty J L, Drake J, Frampton C, et al. Starting dose is a risk factor for allopurinol sensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum 2012;64:2529-36.
  18. Stamp L K, Barclay M L, O'Donnell J L, Zhang M, Drake J, Frampton C, et al. Furosemide increases plasma oxypurinol without lowering serum urate: a complex drug interaction: implications for clinical practice. Rheumatology (Oxford) 2012;51:1670-6.
  19. Gandhi P K, Gentry W M, Bottorf M B. Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system database. Semin Arthritis Rheum 2013;42:562-6.
  20. Becker M A, Schumacher H R, Espinoza L R, Wells A F, MacDonald P, Lloyd E, et al. The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Res Ther 2010;12:R63.
  21. Khanna P P, Fitzgerald J. Evolution of management of gout: a comparison of recent guidelines. Curr Opin Rheumatol 2015;27:139-46.
  22. Burns C M, Wortmann R L. Gout therapeutics: new drugs for an old disease. Lancet 2011;377:165-77.
  23. Chatzipavlou M, Magiorkinis M, Koutsogeorgopoulou L, Kassimos D. Mediterranean diet intervention for patients with hyperuricemia: a pilot study. Rheumatol Int 2014;34:759-62.